androst-4-ene-3,6,17-trione has been researched along with 1,4-androstadiene-3,17-dione in 1 studies
Studies (androst-4-ene-3,6,17-trione) | Trials (androst-4-ene-3,6,17-trione) | Recent Studies (post-2010) (androst-4-ene-3,6,17-trione) | Studies (1,4-androstadiene-3,17-dione) | Trials (1,4-androstadiene-3,17-dione) | Recent Studies (post-2010) (1,4-androstadiene-3,17-dione) |
---|---|---|---|---|---|
17 | 0 | 2 | 107 | 1 | 41 |
Protein | Taxonomy | androst-4-ene-3,6,17-trione (IC50) | 1,4-androstadiene-3,17-dione (IC50) |
---|---|---|---|
Aromatase | Homo sapiens (human) | 0.415 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Covey, DF; Hood, WF | 1 |
1 other study(ies) available for androst-4-ene-3,6,17-trione and 1,4-androstadiene-3,17-dione
Article | Year |
---|---|
A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Topics: Androstadienes; Androstatrienes; Androstenedione; Androstenes; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy; Structure-Activity Relationship; Testolactone | 1982 |